To: President Donald Trump, The United States House of Representatives, and The United States Senate

Continued Immuno-suppressive Drugs for Implant Patients

Continued partial drug coverage for all transplant patients after the current time period following their surgery. These drugs are vital for life so these vital organs are not rejected because of the inability to pay for them.

Why is this important?

It is my understanding that partial Medicare drug coverage will end after 36 mos. following a organ transplant. These drugs are vital for life for all transplant patients and the idea that the inability to pay for these expensive drugs can result in organ rejection is appalling!
Something must be done about this. For instance, it is 4 times more expensive for a patient to be on dialysis than for the
continued coverage of these necessary drugs!